Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters

The in vivo pathogenicity, transmissibility, and fitness of the SARS-CoV-2 Omicron (B.1.1.529) variant are unclear. We compared these virological attributes of this new variant of concern with those of the Delta (B.1.617.2) variant in a Syrian hamster model of COVID-19. Omicron-infected hamsters lost significantly less body weight and exhibited reduced clinical scores, respiratory tract viral burdens, cytokine/chemokine dysregulation, and lung damage than Delta-infected hamsters. Both variants were highly transmissible via contact transmission. In non-contact transmission studies, Omicron demonstrated similar or higher transmissibility than Delta. Delta outcompeted Omicron without selection pressure. This scenario drastically changed once immune selection pressure with neutralizing antibodies active against Delta but poorly active against Omicron was introduced. Next-generation vaccines and antivirals effective against this new VOC are urgently needed.

[1]  L. Poon,et al.  SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo , 2022, Nature.

[2]  Larissa B. Thackray,et al.  SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters , 2022, Nature.

[3]  K. To,et al.  Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron , 2021, Nature.

[4]  T. Makishima,et al.  Recovery of anosmia in hamsters infected with SARS-CoV-2 is correlated with repair of the olfactory epithelium , 2021, Scientific Reports.

[5]  OUP accepted manuscript , 2022, Clinical Infectious Diseases.

[6]  K. To,et al.  SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells , 2021, Emerging microbes & infections.

[7]  T. Ndung’u,et al.  Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization , 2021, Nature.

[8]  Tetsuro Kobayashi,et al.  Relative Reproduction Number of SARS-CoV-2 Omicron (B.1.1.529) Compared with Delta Variant in South Africa , 2021, Journal of clinical medicine.

[9]  P. Maes,et al.  Considerable escape of SARS-CoV-2 Omicron to antibody neutralization , 2021, Nature.

[10]  B. Hoffmann,et al.  Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta , 2021, Nature.

[11]  Qiang Liu,et al.  Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost , 2021, Emerging microbes & infections.

[12]  Fei Shao,et al.  Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies , 2021, bioRxiv.

[13]  Liyuan Liu,et al.  Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 , 2021, Nature.

[14]  A. Telenti,et al.  Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift , 2021, Nature.

[15]  Heidi Ledford.  How severe are Omicron infections? , 2021, Nature.

[16]  T. Cokelaer,et al.  COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters , 2021, Science Translational Medicine.

[17]  Ronald A. Li,et al.  Clofazimine broadly inhibits coronaviruses including SARS-CoV-2 , 2021, Nature.

[18]  K. To,et al.  Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic , 2021, Emerging microbes & infections.

[19]  Carl A. B. Pearson,et al.  Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England , 2021, Science.

[20]  K. To,et al.  Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  Vineet D. Menachery,et al.  Spike mutation D614G alters SARS-CoV-2 fitness , 2020, Nature.

[22]  J. Chan,et al.  Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters , 2020, Nature Microbiology.

[23]  K. To,et al.  Oral SARS-CoV-2 Inoculation Establishes Subclinical Respiratory Infection with Virus Shedding in Golden Syrian Hamsters , 2020, Cell Reports Medicine.

[24]  O. Tsang,et al.  Unique SARS-CoV-2 clusters causing a large COVID-19 outbreak in Hong Kong , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  K. To,et al.  Viruses harness YxxØ motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target , 2020, Science Advances.

[26]  Kenneth Lap-Kei Wu,et al.  SARS-CoV-2 infects and damages the mature and immature olfactory sensory neurons of hamsters , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  Kwok-Hung Chan,et al.  Long SARS-CoV-2 nucleocapsid sequences in blood monocytes collected soon after hospital admission , 2020, bioRxiv.

[28]  Jian-Piao Cai,et al.  Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system , 2020, Pharmacological Research.

[29]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[30]  Dennis Normile,et al.  New SARS-like virus in China triggers alarm. , 2020, Science.